A Comparative Analysis of Liver Injury Markers in Post-COVID Syndrome among Elderly Patients: A Prospective Study
Adrian Vasile Bota,
No information about this author
Felix Bratosin,
No information about this author
Satya Sai Sri Bandi
No information about this author
et al.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(4), P. 1149 - 1149
Published: Feb. 18, 2024
In
the
wake
of
global
COVID-19
pandemic,
understanding
its
prolonged
impact
on
vulnerable
populations
has
become
a
critical
area
investigation.
This
study
aimed
to
elucidate
distinctive
post-acute
sequelae
SARS-CoV-2
infection
(PASC)
and
liver
injury
in
Romania's
elderly
population,
hypothesizing
unique
demographic,
clinical,
healthcare
factors
influencing
manifestation.
A
longitudinal
design
was
employed,
enrolling
patients
from
Victor
Babes
Hospital
for
Infectious
Diseases
Pulmonology
Timisoara,
Romania.
Participants
were
stratified
into
three
groups
based
age
Long
COVID
status.
The
focused
variety
biological
parameters,
including
function
tests,
assess
trajectory
severity
over
six
months
post
discharge.
Involving
238
participants,
revealed
significant
increase
duration
hospitalization
those
65
(15.8
±
8.2
days)
compared
younger
(p
<
0.001).
Notably,
exhibited
marked
elevation
enzymes
discharge,
with
median
ΔALT
ΔAST
24.1
U/L
30.2
U/L,
respectively,
suggesting
ongoing
Significant
metabolic
disruptions
observed,
ΔFasting
glucose
showing
substantial
decrease
21.1
mmol/L
group
pronounced
reduction
ΔGGT
(16.7
U/L)
ΔLDH
(48.7
noted,
indicating
recovery
reduced
tissue
damage
Coagulation
profiles
fibrosis
risk
scores,
particularly
ΔFIB-4
ΔAPRI,
also
significantly
improved
complications.
confirms
hypothesis
more
severe
PASC
among
Romanian
population.
improvements
discharge
suggest
degree
recovery,
yet
persistent
alterations
enzymes,
metabolism,
scores
call
continued
monitoring
tailored
management
strategies.
Language: Английский
Comorbidities and Severe COVID-19 Outcomes: A Retrospective Analysis of Hospitalized Patients in Three Counties in Romania
Réka Bodea,
No information about this author
Septimiu Voidăzan,
No information about this author
Loránd Ferencz
No information about this author
et al.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(4), P. 787 - 787
Published: March 29, 2025
Background:
The
COVID-19
pandemic
represents
a
major
global
health
crisis,
with
clinical
manifestations
ranging
from
asymptomatic
infection
to
fatal
outcomes.
While
all
individuals
are
susceptible,
specific
populations,
particularly
those
pre-existing
medical
conditions,
face
heightened
risk
of
severe
disease.
This
study
aimed
assess
the
prevalence
among
hospitalized
patients
comorbidities
in
Central
Region
Romania,
and
analyze
association
between
these
conditions
mortality.
Methods:
We
conducted
retrospective
cohort
using
data
Corona
Forms
platform
(2020–2022),
encompassing
cases
across
three
Romanian
counties.
A
total
1458
confirmed
SARS-CoV-2
documented
were
included.
Demographic
characteristics,
comorbid
hospitalization
outcomes
analyzed.
Results:
overall
mortality
rate
was
89.3%.
Renal,
neurologic,
hepatic
disease,
cardiovascular
obesity,
type
2
diabetes
mellitus,
cerebrovascular
accidents
significant
factors
for
death
SARS-CoV-2-infected
population.
strength
their
varies,
odds
ratios
25.32
1.
Conclusions:
findings
underscore
critical
impact
on
severity
population,
emphasizing
necessity
targeted
interventions
public
strategies
protect
high-risk
populations.
Language: Английский
The link between the fatal cases with SARS-CoV-2 infection and multimorbidity: Our single institution experience
Laura Chinezu,
No information about this author
Grigore M. Radu,
No information about this author
Purba Wahyu Adi
No information about this author
et al.
Acta Marisiensis. Seria Medica,
Journal Year:
2025,
Volume and Issue:
71(1), P. 31 - 39
Published: March 1, 2025
Abstract
Objective
During
the
pandemic,
SARS-CoV-2
infection
with
its
different
variants
had
determined
high
morbidity
and
mortality.
As
clinical
autopsies
were
reduced
in
our
country,
complete
forensic
provided
important
valuable
information
regarding
pathological
changes
pathophysiological
mechanisms
associated
infection.
Our
aim
was
to
focus
on
of
SARS-CoV-2,
trying
determine
contribution
lethal
outcome
establish
cause
death.
Methods
Complete
performed
cases
confirmed
by
polymerase
chain
reaction
for
All
findings
patient’s
comorbidities
analyzed.
Results
Forty-nine
studied.
Twenty
female
(41%),
29
male
(59%).
The
median
age
at
death
63
years
(range
26-93
years),
an
upward
trend
during
four
SARS-CoV-2.
that
died
due
their
SARS-Cov-2
higher
compared
Two
thirds
hospital,
most
them
less
than
one
week
hospitalization
third
found
dead
home.
Most
without
significant
health
conditions
Conclusions
immediate
many
respiratory
origin
diffuse
alveolar
damage.
evident
represented,
highlight
importance
multimorbidity
development
critical
illness.
Language: Английский
Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(10), P. 2998 - 2998
Published: May 20, 2024
Introduction:
Indonesia,
as
a
developing
country,
has
limited
data
on
the
factors
associated
with
30-day
mortality
in
COVID-19
patients
Indonesia.
As
matter
of
fact,
study
analyzing
infection
Indonesia
never
been
conducted.
This
aims
to
fill
this
gap
literature
by
conducting
large-scale
analysis
Method:
employed
single-center
retrospective
cohort
observational
design,
and
was
conducted
at
Cipto
Mangunkusumo
National
General
Hospital
between
years
2022
2023.
Sampling
using
consecutive
sampling
method.
The
included
aged
18
above
who
had
confirmed
have
infection.
Survival
Kaplan-Meier
multivariate
Cox
regression
analysis.
Result:
Our
total
644
patients,
120
(18.6%)
expiring
within
30
days.
In
backward
Wald
method,
severe
(HR:
7.024;
95%
CI:
3.971-12.744;
p
value:
<0.0001),
moderate
1.660;
1.048-2.629;
0.031),
liver
cirrhosis
3.422;
1.208-9.691;
0.021),
female
sex
1.738;
1.187-2.545;
0.004),
old
age
2.139;
1.279-3.577;
high
leukocyte
11.502;
1.523-86.874;
0.018),
NLR
1.720;
1.049-2.819;
0.032),
CRP
1.906;
1.092-3.329;
0.023),
procalcitonin
3.281;
1.780-6.049;
0.001),
creatinine
1.863;
1.240-2.800;
0.003)
were
from
Subgroup
excluding
cancer
showed
that
age,
D-Dimer,
CRP,
PCT
while
steroid
therapy
is
protective.
Conclusions:
finds
severity,
cirrhosis,
sex,
leukocyte,
NLR,
creatinine,
These
findings
underscore
multifactorial
nature
mortality.
It
important,
therefore,
which
exhibit
these
should
be
treated
more
aggressively
prevent
Language: Английский
Predicting Severe COVID-19 Outcomes in the Elderly: The Role of Systemic Immune Inflammation, Liver Function Tests, and Neutrophil-to-Lymphocyte Ratio
Adrian Vasile Bota,
No information about this author
Felicia Marc,
No information about this author
Adelina Mavrea
No information about this author
et al.
Healthcare,
Journal Year:
2024,
Volume and Issue:
12(23), P. 2429 - 2429
Published: Dec. 3, 2024
:
Patients
aged
80
years
and
above
are
at
increased
risk
for
severe
COVID-19
outcomes.
This
study
aimed
to
evaluate
the
prognostic
utility
of
derived
neutrophil-to-lymphocyte
ratio
(dNLR),
aspartate-aminotransferase-to-lymphocyte
index
(ALRI),
aspartate-aminotransferase-to-platelet
(APRI),
systemic
immune
inflammation
(SII)
in
predicting
disease,
intensive
care
unit
(ICU)
admission,
mortality
among
patients
older.
Language: Английский